Why the study?
Chlorogenic acid is reported to protect against cardiac hypertrophy, but its underlying mechanism of action remains incompletely elucidated.
Population
AC16 cells with isoproterenol-induced cardiac hypertrophy
Comparison
Chlorogenic acid treatment vs untreated controls with or without IM-12
Design
In vitro preclinical mechanistic study
Authors
Loading...
Should not inform practice; extends in vitro evidence for CGA in hypertrophy.
Chlorogenic acid attenuates isoproterenol-induced cardiac hypertrophy in vitro by inhibiting the Wnt/β-catenin signaling pathway, highlighting its potential therapeutic value.
He et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: